Back to search results

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Abroad (travel likely)RecruitingPHASE2

Conditions

Focal Onset Seizure · Primary Generalized Epilepsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Praxis Research Site, Phoenix, Arizona, United States

  • Praxis Research Site, Miami Lakes, Florida, United States

  • Praxis Research Site, Bethesda, Maryland, United States

  • Praxis Research Site, Chesterfield, Missouri, United States

  • Praxis Research Site, Hackensack, New Jersey, United States

  • Praxis Research Site, Middletown, New York, United States

  • Praxis Research Site, Round Rock, Texas, United States

  • Praxis Research Site, Seabrook, Texas, United States

  • Praxis Research Site, Heidelberg, Australia

  • Praxis Research Site, Melbourne, Australia

  • Praxis Research Site, Madrid, Spain

Study leads

  • Medical Director

    Study Director

    Praxis Precision Medicines

View source on ClinicalTrials.gov(opens in a new tab)